Patents Assigned to UNIVERSITY HOSPITAL ANTWERP
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20220160727
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 8, 2022
    Publication date: May 26, 2022
    Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20210121479
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: June 12, 2020
    Publication date: April 29, 2021
    Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20200030341
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: October 8, 2019
    Publication date: January 30, 2020
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • Method for the treatment of Dravet Syndrome
    Patent number: 10478442
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: November 19, 2019
    Assignees: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten Ceulemens, Lieven Lagae
  • Method for the treatment of Dravet syndrome
    Patent number: 10478441
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: November 19, 2019
    Assignees: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten Ceulemens, Lieven Lagae
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20170151214
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20170151213
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20170151257
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20170151194
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20170151259
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicants: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten CEULEMENS, Lieven LAGAE
  • Method for the treatment of Dravet Syndrome
    Patent number: 9610260
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: April 4, 2017
    Assignees: The Katholieke Universiteit Leuven, University Hospital Antwerp
    Inventors: Berten Ceulemens, Lieven Lagae
  • Method for the treatment of Dravet syndrome
    Patent number: 9603814
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: March 28, 2017
    Assignees: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten Ceulemens, Lieven Lagae
  • Method for the treatment of Dravet syndrome
    Patent number: 9603815
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: March 28, 2017
    Assignees: THE KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten Ceulemens, Lieven Lagae
  • Method for the treatment of dravet syndrome
    Patent number: 9549909
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: January 24, 2017
    Assignees: The Katholieke Universiteit Leuven, University Hospital Antwerp
    Inventors: Berten Ceulemens, Lieven Lagae
  • METHOD FOR THE TREATMENT OF DRAVET SYNDROME
    Publication number: 20160136114
    Abstract: A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.
    Type: Application
    Filed: January 21, 2016
    Publication date: May 19, 2016
    Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITY HOSPITAL ANTWERP
    Inventors: Berten Ceulemens, Lieven Lagae